February 26, 2018
Magenta Therapeutics Presents Clinical and Preclinical Data at ASBMT Conference, Including New Preclinical Results on Microglial Engraftment with MGTA-456 Expanded Cord Blood Stem Cell Product
February 21, 2018
Magenta Therapeutics Hires John Davis, MD, MPH, as Chief Medical Officer
The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Magenta disavows any obligation to update the information contained in such press releases after the date of their issuance.